
|Videos|September 10, 2021
Analyzing classifications of macula dystrophies
Author(s)David Hutton, Alex Delaney-Gesing
Carel B. Hoyng, MD, discusses his presentation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.
Advertisement
Carel B. Hoyng, MD, professor at the Radboud University Medical Center, Department Ophthalmology, Nijmegen, The Netherlands, discusses his presenation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
The gene therapy shift: A closer look at the science powering next-generation retinal treatments
2
How European clinicians are revolutionizing retina care
3
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
4
Managing Geographic Atrophy in a 90-Year-Old Patient with Coexisting Neovascular AMD and Recurrent CNV Activation
5












































